Our experience with Cleveland Clinic, Steris and other high-tech medical companies made A.M. Design Group a perfect fit for assisting Juventas Therapeutics. Juventas is a privately-held biotechnology company that develops regenerative therapies to treat life-threatening diseases, specifically cardiovascular disease.

Their primary product, Stromal-cell Derived Factor 1 (SDF-1), has been shown to protect and repair damaged organ tissue following a heart-attack. This novel therapy recruits the body’s own stem cells to bring healing to the damaged region. Thus, their business truly is “mending broken hearts.”

A.M. Design Group’s development of their new web site coincides with preparation to begin a Phase I clinical trial using SDF-1 for the treatment of chronic heart failure in the beginning of 2010. We covet opportunities to work with companies that lead their industry, in life-changing ways like Juventas.

Click here to jump to the new website, or click here to request more information about our web design capabilities